Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00812513Phase 2Unknown
A Phase 2 trial of becaplermin in burn injury, electrical burn, sponsored by American Scitech International. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00812513.